In the name of common sense: EUCAST breakpoints and potential pitfalls

被引：11
|
作者：
Meylan, Sylvain [1 ,2 ]
Guery, Benoit
机构：
[1] Univ Lausanne, Dept Med, Infect Dis Serv, Rue Bugnon 46, CH-1011 Lausanne, Switzerland
[2] Lausanne Univ Hosp, Rue Bugnon 46, CH-1011 Lausanne, Switzerland
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2020年 / 26卷 / 12期
关键词：
Antibiogram; Antimicrobial therapy; Antimicrobials; Breakpoints; EUCAST;
D O I：
10.1016/j.cmi.2020.07.025
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1593 / 1594
页数：2
相关论文
共 50 条
  • [21] Ceftaroline Susceptibility among Isolates of MRSA: A Comparison of EUCAST and CLSI Breakpoints
    Sachu, Arun
    ETHIOPIAN JOURNAL OF HEALTH SCIENCES, 2023, 33 (01) : 143 - 150
  • [22] A Pragmatic Approach to Susceptibility Classification of Yeasts without EUCAST Clinical Breakpoints
    Astvad, Karen Marie Thyssen
    Arikan-Akdagli, Sevtap
    Arendrup, Maiken Cavling
    JOURNAL OF FUNGI, 2022, 8 (02)
  • [23] EUCAST definitive document E. Def 4.1 - Linezolid breakpoints
    CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (05) : 283 - 284
  • [24] Validation of EUCAST zone diameter breakpoints against reference broth microdilution
    Bengtsson, S.
    Bjelkenbrant, C.
    Kahlmeter, G.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (06) : O353 - O360
  • [25] Making Sense of Declarative Process Models: Common Strategies and Typical Pitfalls
    Haisjackl, Cornelia
    Zugal, Stefan
    Soffer, Pnina
    Hadar, Irit
    Reichert, Manfred
    Pinggera, Jakob
    Weber, Barbara
    ENTERPRISE, BUSINESS-PROCESS AND INFORMATION SYSTEMS MODELING, BPMDS 2013, 2013, 147 : 2 - 17
  • [26] EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents
    Arendrup, M. C.
    Meletiadis, J.
    Mouton, J. W.
    Guinea, J.
    Cuenca-Estrella, M.
    Lagrou, K.
    Howard, S. J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (06) : 571.e1 - 571.e4
  • [27] Updated EUCAST Clinical Breakpoints against Aspergillus, Implications for the Clinical Microbiology Laboratory
    Guinea, Jesus
    JOURNAL OF FUNGI, 2020, 6 (04) : 1 - 11
  • [28] THE SENSE OF A NAME
    LUNTLEY, M
    PHILOSOPHICAL QUARTERLY, 1984, 34 (136): : 265 - 282
  • [29] Tigecycline and intravenous fosfomycin zone breakpoints equivalent to the EUCAST MIC criteria for Enterobacteriaceae
    Pasteran, Fernando
    Lucero, Celeste
    Rapoport, Melina
    Guerriero, Leonor
    Barreiro, Irene
    Albornoz, Ezequiel
    Veliz, Omar
    Corso, Alejandra
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2012, 6 (05): : 452 - 456
  • [30] Comparison of antimicrobial susceptibility interpretation among Enterobacteriaceae using CLSI and EUCAST breakpoints
    Swathi, Suravaram
    Vivek, Hada
    Siddiqui, Imran Ahmed
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2021, 39 (03) : 315 - 319
12345